Igs2em62(tetO-APOBEC1*/cas9*,CAG-rtTA)Gpt
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Igs2em62(tetO-APOBEC1*/cas9*,CAG-rtTA)Gpt |
| Name: |
intergenic site 2; endonuclease-mediated mutation 62, GemPharmatech Co., Ltd |
| MGI ID: |
MGI:7300675 |
| Synonyms: |
Igs2em1Cin(pTRE3G-YE1-BE4max-rTTA-CAG) |
| Gene: |
Igs2 Location: Chr11:3195460-3195497 bp Genetic Position: Chr11, Syntenic
|
| Alliance: |
Igs2em62(tetO-APOBEC1*/cas9*,CAG-rtTA)Gpt page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Endonuclease, Inducible, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: CRISPR-targeting inserted a tetracycline response element driving inducible expression of a recombinant APOBEC1 (W90Y, R126E) fused with a cas( containing the amino acid substitution of aspartic acid with alanine at position 10 (D10A). The insertion also contains a CAG promoter dirving ubiquitous expression of a reverse tetracycline transactivator.
(J:293217)
|
| Inheritance: |
|
Not Specified |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Igs2 Mutation: |
69 strains or lines available
|
|
|
|